Qualsody/Toferson conceived by CNS Director Dr. Smith and developed in collaboration with Don Cleveland (UCSD), Tim Miller (WashU), and Frank Bennett (Ionis Pharmaceuticals), has been approved by the European Union for the treatment of a familial form of Amyotrophic lateral sclerosis (ALS). Read more here.
top of page
News
The open access version of "Chinese Translation and Validation of the Center for Neurologic Study Lability Scale" has been published in the online library of Neurology and Therapy and can be accessed here: https://link.springer.com/article/10.1007/s40120-024-00605-w?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20240416&utm_content=10.1007/s40120-024-00605-w
Nature Neurology Reviews has highlighted a publication authored by Dr. Smith and colleagues regarding the identification of sporadic ALS patients in whom a self-replicating protein has been identified in the spinal fluid (European Journal of Neurology, 2024).
bottom of page